14-09-2018
Xesai / iStockphoto.com
Johnson & Johnson (J&J) announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Johnson & Johnson, J&J, Emerging Implant Technologies, acquisition, surgery, orthopaedics, technology, medical devices, 3D Printing
Globus launches patent suit over spinal implant tech
14-10-2021
7th Circuit won’t overturn spinal implant injunction
10-08-2021
J&J to buy surgical robotics company for $3.4bn
18-02-2019
J&J plans to sell LifeScan for $2.1bn
21-03-2018
Johnson & Johnson reveals obesity and 3D printing collaborations
16-06-2017
